Certified by Founder Lodge
Agent Capital
United States - Waltham, MA
INVESTOR
1 Disclosed Funding Rounds $123,000,000
8 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Agent Capital is a healthcare investment firm focused on novel technologies and therapeutics that address unmet patient need. Our investment areas of focus are new products and technologies f
| Company | Date | Round | Raised |
|---|---|---|---|
 Flare Therapeutics |
March, 23 ,2023 | Series B | $123,000,000 |
 Orbital Therapeutics |
April, 27 ,2023 | Series A | $270,000,000 |
 Foresight Diagnostics Inc. |
April, 28 ,2023 | Series B | $58,750,000 |
 Star Therapeutics |
September, 05 ,2023 | Series C | $90,000,000 |
 Jana Care |
November, 09 ,2023 | Unknown | $6,000,000 |
 Cerevance |
April, 26 ,2024 | Series B | $47,000,000 |
 TRexBio |
November, 14 ,2024 | Series B | $84,000,000 |
 Hone Health |
January, 29 ,2025 | Series A | $33,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
UPTIQ | $12,000,000 | (Oct 29, 2025)
Flamingo(US) | $2,200,000 | (Oct 29, 2025)
Lula Commerce | $8,000,000 | (Oct 29, 2025)
Cylerity | $4,000,000 | (Oct 29, 2025)
Syllo | $30,000,000 | (Oct 29, 2025)
